ECCO Topical Review on Pouch Disorders - Summary - MDSpire

ECCO Topical Review on Pouch Disorders

  • By

  • Maia Kayal

  • Gabriele Bislenghi

  • Michel Adamina

  • Zaid S Ardalan

  • Nicolas Avellaneda

  • Anthony de Buck van Overstraeten

  • Marjolijn Duijvestein

  • Maria Manuela Estevinho

  • Federica Furfaro

  • Ailsa L Hart

  • Stefan Holubar

  • Triana Lobaton

  • Jacob Ollech

  • Stephan R Vavricka

  • Marc Ferrante

  • July 17, 2025

  • 0 min

Share

Objective:

To provide expert consensus practice recommendations for the diagnosis and management of common inflammatory, functional, structural, and neoplastic J-pouch disorders, including acute pouchitis and chronic conditions.

Key Findings:
  • Pouch disorders commonly present with increased stool frequency, urgency, incontinence, pelvic cramping, obstructed defecation, and perianal drainage.
  • Acute pouchitis has an incidence rate of 70-80% in long-term follow-up, with a significant recurrence rate.
  • Diagnosis of acute pouchitis involves clinical history and pouchoscopy, with fecal calprotectin as a potential diagnostic aid.
Interpretation:

A multidisciplinary approach is essential for effective diagnosis and management of pouch disorders, highlighting the need for high-quality evidence, which is currently limited for many conditions.

Limitations:
  • Evidence for most pouch disorders is limited and of low quality, which may affect clinical decision-making.
  • The consensus positions are based on available scientific data and expert opinion, which may not cover all clinical scenarios.
Conclusion:

The review emphasizes the importance of a comprehensive and multidisciplinary approach to managing pouch disorders, highlighting the need for further research to improve evidence quality.

Original Source(s)

ECCO Topical Review on Pouch Disorders

  • by Maia Kayal, Gabriele Bislenghi, Michel Adamina, Zaid S Ardalan, Nicolas Avellaneda, Anthony de Buck van Overstraeten, Marjolijn Duijvestein, Maria Manuela Estevinho, Federica Furfaro, Ailsa L Hart, Stefan Holubar, Triana Lobaton, Jacob Ollech, Stephan R Vavricka, Marc Ferrante

  • July 17, 2025

Related Content

Ethosuximide vs Placebo for IBS Pain

Randomized trial found no improvement in abdominal pain and higher discontinuation rates with the calcium channel blocker.

Incidence of Clostridium difficile infection and enteric pathogens in children with inflammatory bowel disease presenting with disease exacerbation

Mortality trends from colorectal pathologies in the United States (1999–2020): a retrospective cohort study using CDC WONDER